Leukoplakia in HIV patients and risk of malignancy: A case report
Downloads
Downloads
Mortazavi H, Baharvand M, Mehdipour M. Oral potentially malignant disorders: an overview of more than 20 entities. J Dent Res Dent Clin Dent Prospects. 2014; 8(1): 6–14.
Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125(6): 612–27.
Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: A systematic review of observational studies. J Oral Pathol Med. 2016; 45(3): 155–66.
van der Waal I. Historical perspective and nomenclature of potentially malignant or potentially premalignant oral epithelial lesions with emphasis on leukoplakia”some suggestions for modifications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125(6): 577–81.
van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015; 20(6): e685–92.
Bobat R, Archary M. HIV infection. In: Green RJ, editor. Viral Infections in Children, Volume I. Spinger; 2017. p. 69–100.
Ditjen P2P Kementrian Kesehatan Republik Indonesia. Laporan perkembangan situasi HIV-AIDS & PIMS di Indonesia Januari-Desember 2017. Jakarta; 2018. p. 560.
Lima JS, Pinto DDS, De Sousa SOM, Corríªa L. Oral leukoplakia manifests differently in smokers and non-smokers. Braz Oral Res. 2012; 26(6): 543–9.
Villa A, Woo S Bin. Leukoplakia”A diagnostic and management algorithm. J Oral Maxillofac Surg. 2017; 75(4): 723–34.
Kayalvizhi EB, Lakshman VL, Sitra G, Yoga S, Kanmani R, Megalai N. Oral leukoplakia: A review and its update. J Med Radiol Pathol Surg. 2016; 2: 18–22.
Ribeiro AS, Salles PR, da Silva TA, Mesquita RA. A review of the nonsurgical treatment of oral leukoplakia. Int J Dent. 2010; 2010(2): 1–10.
Deliverska EG, Petkova M. Management of oral leukoplakia - Analysis of the literature. J IMAB - Annu Proceeding (Scientific Pap. 2017; 23(1): 1495–504.
Borges A, Dubrow R, Silverberg M. Factors contributing to risk for cancer among HIV-infected individuals and evidence that earlier cART will alter risk. Curr Opion HIV AIDS. 2014; 9(1): 34–40.
Farah CS, Jessri M, Currie S, Alnuaimi A, Yap T, McCullough MJ. Aetiology of oral cavity cancer. In: Kuriakose MA, editor. Contemporary Oral Oncology. Springer; 2017. p. 31–76.
Silverberg MJ, Chao C, Leyden WA, Tang B, Horberg MA, Klein D, Charles P, Jr Q, Towner WJ, Abrams DI. HIV infection and the risk of cancer with and without a known infectious cause. AIDS. 2009; 23(17): 2337–45.
Seo J, Utumi ER, Zambon CE, Pedron IG, Ceccheti MM. Use of retinoids in the treatment of oral leukoplakia: review. Rev Clín Pesq Odontol Curitiba. 2010; 6(2): 149–54.
Salati NA. Clinico-pathologic evaluation & medical treatment of oral leukoplakia. Int J Pharm Sci Invent. 2014; 3(2): 7–12.
- Every manuscript submitted to must observe the policy and terms set by the Dental Journal (Majalah Kedokteran Gigi).
- Publication rights to manuscript content published by the Dental Journal (Majalah Kedokteran Gigi) is owned by the journal with the consent and approval of the author(s) concerned.
- Full texts of electronically published manuscripts can be accessed free of charge and used according to the license shown below.
- The Dental Journal (Majalah Kedokteran Gigi) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License